Company Filing History:
Years Active: 2009
Title: Andrea Zaliani: Innovator in Glucokinase Activators
Introduction
Andrea Zaliani is a prominent inventor based in Hamburg, Germany. She has made significant contributions to the field of pharmaceuticals, particularly in the development of glucokinase activators. Her innovative work has led to the filing of a patent that showcases her expertise and dedication to advancing medical science.
Latest Patents
Andrea Zaliani holds a patent for "Substituted arylcyclopropylacetamides as glucokinase activators." This invention provides compounds of formula (I) and pharmaceutically acceptable salts thereof. The patent highlights her commitment to creating effective solutions for health-related challenges.
Career Highlights
Throughout her career, Andrea has worked with notable companies, including Eli Lilly and Company and Thomas J.C. Matzen GmbH. Her experience in these organizations has allowed her to refine her skills and contribute to groundbreaking research in the pharmaceutical industry.
Collaborations
Andrea has collaborated with esteemed colleagues such as Andreas Gerhard Weichert and David Gene Barrett. These partnerships have further enriched her work and expanded the impact of her inventions.
Conclusion
Andrea Zaliani is a remarkable inventor whose work in glucokinase activators has the potential to influence the pharmaceutical landscape significantly. Her dedication to innovation and collaboration underscores her importance in the field.
Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.